TNF and necrotizing enterocolitis: Donor-specific differences in FITC-dextran translocation at baseline and with EGTA treatment are shown in Fig. S4A and B. Tumor necrosis factor-α (TNFα), often used to simulate NEC in vitro, is also regarded as a modulator of epithelial permeability (36, 37).